Literature DB >> 28970640

A COMPARISON OF MAZUR'S k AND AREA UNDER THE CURVE FOR DESCRIBING STEEP DISCOUNTERS.

Jin H Yoon1, Richard De La Garza1, Thomas F Newton1, Robert Suchting1, Matthew T Weaver2, Gregory S Brown1, Yasmine Omar1, Ilana Haliwa1.   

Abstract

Delay discounting describes how a reward loses value as a function of increasing delay to its receipt and has been reliably associated with a variety of vulnerable populations including those with substance use disorders (SUDs). Two commonly used models to assess delay discounting in the field of SUDs include log k derived from Mazur's hyperbolic equation and area under the curve (AUC). In the current study, we compared log k with AUC on delay discounting data obtained from non-treatment seeking, cocaine- and methamphetamine-dependent volunteers. We specifically chose this population in order to obtain a distribution of relatively steep discounters. The results show that the relationship between AUC and log k is better described by a quadratic rather than a linear function. In other words, changes in discounting, as measured by AUC and log k, are reflected differently across a range of obtained responses. Additionally, the distribution of AUC values was skewed, which appears to be more likely among populations exhibiting greater discounting. Finally, closer examination of indifference points revealed that AUC was almost perfectly predicted by the area from the two longest delays, with relatively less input from shorter delays. Given these results, researchers should exercise additional caution when deciding which method to assess discounting data and how final results are to be interpreted, particularly when dealing with relatively high rates of discounting. High rates of discounting are likely in populations with impulsive disorders such as those with SUDs.

Entities:  

Keywords:  area under the curve; cocaine; delay discounting; impulsivity; methamphetamine

Year:  2017        PMID: 28970640      PMCID: PMC5621750          DOI: 10.1007/s40732-017-0220-9

Source DB:  PubMed          Journal:  Psychol Rec        ISSN: 0033-2933


  24 in total

Review 1.  Toward a behavioral economic understanding of drug dependence: delay discounting processes.

Authors:  W K Bickel; L A Marsch
Journal:  Addiction       Date:  2001-01       Impact factor: 6.526

Review 2.  A discounting framework for choice with delayed and probabilistic rewards.

Authors:  Leonard Green; Joel Myerson
Journal:  Psychol Bull       Date:  2004-09       Impact factor: 17.737

Review 3.  A review of delay-discounting research with humans: relations to drug use and gambling.

Authors:  Brady Reynolds
Journal:  Behav Pharmacol       Date:  2006-12       Impact factor: 2.293

4.  Turning k on its head: comments on use of an ED50 in delay discounting research.

Authors:  Jin H Yoon; Stephen T Higgins
Journal:  Drug Alcohol Depend       Date:  2008-02-19       Impact factor: 4.492

5.  A systematic assessment of delay discounting in relation to cocaine and nicotine dependence.

Authors:  Olaya García-Rodríguez; Roberto Secades-Villa; Sara Weidberg; Jin Ho Yoon
Journal:  Behav Processes       Date:  2013-07-17       Impact factor: 1.777

6.  Impulsivity and rapid discounting of delayed hypothetical rewards in cocaine-dependent individuals.

Authors:  Scott F Coffey; Gregory D Gudleski; Michael E Saladin; Kathleen T Brady
Journal:  Exp Clin Psychopharmacol       Date:  2003-02       Impact factor: 3.157

7.  The relationship between impulsivity and craving in cocaine- and methamphetamine-dependent volunteers.

Authors:  Desey Tziortzis; James J Mahoney; Ari D Kalechstein; Thomas F Newton; Richard De La Garza
Journal:  Pharmacol Biochem Behav       Date:  2011-01-06       Impact factor: 3.533

8.  The angiotensin-converting enzyme inhibitor perindopril treatment alters cardiovascular and subjective effects of methamphetamine in humans.

Authors:  Thomas F Newton; Richard De La Garza; Ken Grasing
Journal:  Psychiatry Res       Date:  2010-05-20       Impact factor: 3.222

9.  Delay discounting predicts postpartum relapse to cigarette smoking among pregnant women.

Authors:  Jin H Yoon; Stephen T Higgins; Sarah H Heil; Rena J Sugarbaker; Colleen S Thomas; Gary J Badger
Journal:  Exp Clin Psychopharmacol       Date:  2007-04       Impact factor: 3.157

Review 10.  Food reinforcement, delay discounting and obesity.

Authors:  Leonard H Epstein; Sarah J Salvy; Katelyn A Carr; Kelly K Dearing; Warren K Bickel
Journal:  Physiol Behav       Date:  2010-05-21
View more
  6 in total

1.  Single- and cross-commodity delay discounting of money and e-cigarette liquid in experienced e-cigarette users.

Authors:  Irene Pericot-Valverde; Jin H Yoon; Diann E Gaalema
Journal:  Drug Alcohol Depend       Date:  2019-11-15       Impact factor: 4.492

Review 2.  Dissecting drug effects in preclinical models of impulsive choice: emphasis on glutamatergic compounds.

Authors:  Justin R Yates
Journal:  Psychopharmacology (Berl)       Date:  2018-01-06       Impact factor: 4.530

Review 3.  Clinical models of decision making in addiction.

Authors:  Mikhail N Koffarnus; Brent A Kaplan
Journal:  Pharmacol Biochem Behav       Date:  2017-08-26       Impact factor: 3.533

4.  Bleak present, bright future: II. Combined effects of episodic future thinking and scarcity on delay discounting in adults at risk for type 2 diabetes.

Authors:  Jeffrey S Stein; William H Craft; Rocco A Paluch; Kirstin M Gatchalian; Mark H Greenawald; Teresa Quattrin; Lucy D Mastrandrea; Leonard H Epstein; Warren K Bickel
Journal:  J Behav Med       Date:  2020-09-28

5.  A story to tell: the role of narratives in reducing delay discounting for people who strongly discount the future.

Authors:  Leonard H Epstein; Tatiana Jimenez-Knight; Anna M Honan; Mathew J Biondolillo; Rocco A Paluch; Warren K Bickel
Journal:  Memory       Date:  2021-06-03

6.  Assessment of demand for methamphetamine and cigarettes among individuals with methamphetamine use disorder.

Authors:  Jin H Yoon; Robert Suchting; Rachel N Cassidy; Peter K Bolin; Yasmine Omar; Gregory S Brown; Richard De La Garza
Journal:  Exp Clin Psychopharmacol       Date:  2020-03-23       Impact factor: 3.492

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.